An emerging concept in mechanisms that lead to neuropathic pain is elevated intracellular levels of reactive oxygen species (ROS) in peripheral and central sensitization. The overall hypothesis of the PPG is that ROS act as key signaling molecules in concert with other signaling pathways involved in sensitization. In that context, the present proposal examines spinal cord injury (SCI) induced chronic central neuropathic pain (CNP). This is a major public health problem;consequently, an understanding of the mechanisms of CNP will lead to opportunities for treatment of this terrible condition. We will use the rodent spinal cord contusion model because this model best approximates human SCI. CNP in this model includes above level (C7/C8, forelimb innervation), at level (T8, trunk innervation) and below level (L4/L5, hindlimb innervation) pain-like behaviors seen clinically. CNP is thought to be generated in these different clinically relevant regions by different mechanisms. In this project, we will test the hypothesis that generation of ROS after SCI contributes to central neuropathic pain by both peripheral and central sensitization via activated calcium/calmodulin kinase II (pCamKII) pathways. We will test the following specific aims: 1) Determine the time course of development of CNP behavior in the rodent contusion model. 2) Determine the time course of development of central and peripheral sensitization above level, at level and below level after SCI. 3) Test the sites of action of ROS inhibitors and the effects of these substances separately at those sites on CNP behaviors early and in chronic SC and on pCamKII expression levels. 4) Determine the effect of ROS inhibition (by the most effective agent and route determined by behavioral outcomes in Specific Aim 3) on central and peripheral sensitization early and in chronic SCI and on ROS expression levels. Outcome measures include behavior, electrophysiology, protein expression and immunocytochemistry. Our results will expand on Project 1 (ROS in peripheral sensitization after inflammation), Project 3 (role of ROS in C-fiber driven central sensitization) and Project 4 (role of ROS in amygdala and central sensitization) to give insight into mechanisms that provide common bases for development and maintenance of CNP and indicate therapeutically useful strategies for intervention in neuropathic and inflammatory pain syndromes.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Program Projects (P01)
Project #
Application #
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Medical Br Galveston
United States
Zip Code
Carter, Michael W; Johnson, Kathia M; Lee, Jun Yeon et al. (2016) Comparison of Mechanical Allodynia and Recovery of Locomotion and Bladder Function by Different Parameters of Low Thoracic Spinal Contusion Injury in Rats. Korean J Pain 29:86-95
Hammell, D C; Zhang, L P; Ma, F et al. (2016) Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain 20:936-48
Young, E E; Bryant, C D; Lee, S E et al. (2016) Systems genetic and pharmacological analysis identifies candidate genes underlying mechanosensation in the von Frey test. Genes Brain Behav 15:604-15
Yuan, Su-Bo; Ji, Guangchen; Li, Bei et al. (2015) A Wnt5a signaling pathway in the pathogenesis of HIV-1 gp120-induced pain. Pain 156:1311-9
Ji, Guangchen; Li, Zhen; Neugebauer, Volker (2015) Reactive oxygen species mediate visceral pain-related amygdala plasticity and behaviors. Pain 156:825-36
Neugebauer, Volker (2015) Amygdala pain mechanisms. Handb Exp Pharmacol 227:261-84
Hassler, Shayne N; Johnson, Kathia M; Hulsebosch, Claire E (2014) Reactive oxygen species and lipid peroxidation inhibitors reduce mechanical sensitivity in a chronic neuropathic pain model of spinal cord injury in rats. J Neurochem 131:413-7
Ji, Guangchen; Neugebauer, Volker (2014) CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model. Eur J Neurosci 39:455-66
Medina, Georgina; Ji, Guangchen; Gr├ęgoire, St├ęphanie et al. (2014) Nasal application of neuropeptide S inhibits arthritis pain-related behaviors through an action in the amygdala. Mol Pain 10:32
Kiritoshi, Takaki; Sun, Hao; Ren, Wenjie et al. (2013) Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1. Neuropharmacology 66:170-8

Showing the most recent 10 out of 585 publications